Domov › Rak dojke › Distrikta Columbia › Washington
Klinične študije za Rak dojke v Washington, DC
46 študij za Rak dojke išče udeležence na lokacijah v Washington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Vključevanje udeležencevFaza 3
- Georgetown University Medical Center, Washington D.C.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Vključevanje udeležencevFaza 3
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · 7 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Genomic Services Research Program
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Older Breast Cancer Patients: Risk for Cognitive Decline
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Georgetown University, Washington D.C.
Collection of Blood From Patients With Cancer
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Vključevanje udeležencevFaza 3
- Holy Cross Hospital ( Site 0073), Silver Spring · 7 mi stran
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- The George Washington Medical facility Associates, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 mi stran
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Vključevanje udeležencevFaza 3
- Georgetown Uni Hospital, Washington D.C.
- Medstar Research Institute, Hyattsville · 6 mi stran
Identifying Patterns in the Breath of Individuals With Breast Cancer
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- GW Comprehensive Breast Center, Washington D.C.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- Georgetown University Medical Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
- in še 1
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Vključevanje udeležencevFaza 1
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Vključevanje udeležencevFaza 1/2
- Georgetown University, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Vključevanje udeležencevFaza 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 mi stran
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- in še 5
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Vključevanje udeležencevFaza 2
- Georgetown University Medical Center, Washington D.C.
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Vključevanje udeležencev
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Vključevanje udeležencev
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Vključevanje udeležencevFaza 3
- Sibley Memorial Hospital, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Vključevanje udeležencevFaza 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Vključevanje udeležencev
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Vključevanje udeležencevFaza 3
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
E-Mindfulness Approaches for Living After Breast Cancer
Vključevanje udeležencevFaza 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- in še 2
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Vključevanje udeležencevFaza 2
- National Institute of Health Clinical Center, Bethesda · 7 mi stran
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Vključevanje udeležencevFaza 3
- American Oncology Partners, P.A., Bethesda · 7 mi stran
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Vključevanje udeležencevFaza 2
- Georgetown University Medical Center, Washington D.C.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Vključevanje udeležencevFaza 3
- MedStar Washington Hospital Center, Washington D.C.
- Maryland Oncology Hematology P.A., Silver Spring · 7 mi stran
- Maryland Oncology Hematology P.A., Bethesda · 7 mi stran
- in še 1
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Vključevanje udeležencevFaza 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
- in še 2
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Cancer Support Community Research & Training Institute, Washington D.C.
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Vključevanje udeležencevFaza 2
- Georgetown University, Washington D.C.
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Vključevanje udeležencevFaza 2
- George Washington-Medical Faculty Associates, Washington D.C.
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
Vključevanje udeležencev
- Sibley Memorial Hospital, Washington D.C.
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Vključevanje udeležencevOpazovalna študija
- Holy Cross Hospital - Silver Spring, Silver Spring · 7 mi stran
- The Center for Cancer and Blood Disorders - Bethesda, Bethesda · 7 mi stran
Study in Patients With Breast Cancer Leptomeningeal Metastasis
Vključevanje udeležencevOpazovalna študija
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi stran
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi stran
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Vključevanje udeležencev
- Georgetown University, Washington D.C.
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Vključevanje udeležencevOpazovalna študija
- Maryland Oncology Hematology, PA, Silver Spring · 7 mi stran
- Maryland Oncology Hematology - Bethesda, Bethesda · 7 mi stran
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Vključevanje udeležencevOpazovalna študija
- George Washington University, Washington D.C.
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Washington
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak55 študij
- Metastatski rak43 študij
- Rak pljuč41 študij
- Rak prostate38 študij
- Debelost33 študij
- Kolorektalni rak29 študij
- Srčno-žilne bolezni28 študij
- Rak mehurja26 študij
- Akutna mieločna levkemija24 študij
- Rak jajčnikov23 študij
- Limfom23 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.